Fact sheet: PlrCp GblHlthcr G&IPLC

Fund information

Fund name
Polar Capital Global Healthcare Trust PLC Ord 25P
Fund company manager
Polar Capital Partners Ltd
Fund type
ITR
Fund manager
Dan Mahony
since 15/06/2010
Fund objective
To generate capital growth and income by investing in a global portfolio of healthcare stocks.
Benchmark
MSCI AC World Healthcare (N) Index
Investment style
-
Investment method
-

Performance snapshot

Quick stats

1 Year return

34.62 %

1 Year rank in sector

4/4

Sector

IT Biotechnology & Healthcare

Yield

2.3733

Fund size

£ 261.4 m

FE Risk score

145

NAV

220.15

Discount/Premium

+-1.4308

Gearing

100

Top in sector

Holdings snapshot

  • USA
    46.3%
  • UK
    11.1%
  • Switzerland
    9.8%
  • France
    5.7%
  • Japan
    5.7%
  • Pharmaceuticals
    59.2%
  • Healthcare & Medical Products
    9.5%
  • Health Care
    9.2%
  • Biotechnology/Medical
    6%
  • Health Care - Property
    5.7%
  • US Equities
    46.3%
  • UK Equities
    11.1%
  • Swiss Equities
    9.8%
  • French Equities
    5.7%
  • Japanese Equities
    5.7%

Performance vs. Sector

Cumulative performance

1m6m1y3y5y
Fund7.23 %13.95 %35.84 %52.48 %118.82 %
Sector8.71 %15.55 %41.54 %82.25 %201.36 %
Rank within sector5 / 53 / 54 / 44 / 44 / 4
Quartile th4 th3 rd4 th4 th4 th

Calendar performance

YTD-20172016201520142013
Fund12.78 %17.1 %3.99 %22.46 %17.93 %
Sector15.24 %6.22 %12.73 %39.34 %43.24 %
Rank within sector5 / 51 / 44 / 44 / 44 / 4
Quartile th4 th1 st4 th4 th4 th

Risk statistics

Alpha7.22
Beta0.32
Sharpe0.84
Volatility12.31
Tracking error17.2
Information ratio-0.34
R-Squared0.27

Price movement

52 week high218
52 week low164.75
Current bid price217
Current offer price218.25
Current mid price217

Holdings by region

  • 46.3% USA
  • 11.1% UK
  • 9.8% Switzerland
  • 5.7% France
  • 5.7% Japan
  • 5.6% Money Market
  • 5.1% Germany
  • 4.3% Others
  • 3.6% Ireland
  • 2.8% Australia

Holdings by sector

  • 59.2% Pharmaceuticals
  • 9.5% Healthcare & Medical Products
  • 9.2% Health Care
  • 6% Biotechnology/Medical
  • 5.7% Health Care - Property
  • 5.5% Money Market
  • 3.4% Hospital
  • 1.5% Others

Holdings by asset type

  • 46.3% US Equities
  • 11.1% UK Equities
  • 9.8% Swiss Equities
  • 5.7% French Equities
  • 5.7% Japanese Equities
  • 5.6% Money Market
  • 5.1% German Equities
  • 4.3% International Equities
  • 3.6% Irish Equities
  • 2.8% Australian Equities

Individual holdings

  • 7.4% MERCK & CO INC(NEW)
  • 7.1% PFIZER INC
  • 6.3% JOHNSON & JOHNSON
  • 5.7% SANOFI
  • 5.3% GLAXOSMITHKLINE PLC
  • 4.8% NOVARTIS AG
  • 4.5% MERCK KGAA
  • 4.2% ROCHE HLDG AG
  • 3.3% ASTELLAS PHARMA INC
  • 3.2% BRISTOL MYERS SQUIBB SA